CLMS News Alert Calamos Asset Management (CLMS) 12.41 12/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Calamos Asset Management (CLMS) 12.41 $CLMS

REVISED: Calamos Focus Growth Exchange Traded Fund (NASDAQ: CFGE) Announces Annual Distribution for December 2014
PR Newswire - Mon Dec 01, 4:39PM CST
Calamos Investments®* announced today the revision of the record date and ex-dividend date for the annual distribution on each common share for its actively managed exchange traded fund, Calamos Focus Growth ETF (NASDAQ: CFGE). Only the dates have been revised. The distribution amounts previously released are unchanged.
CLMS: 12.41 (-0.50), CFGE: 10.27 (-0.02)

Calamos Releases Quarterly Global Economic Review and Outlook October 2014
PR Newswire Europe - Wed Nov 26, 4:18PM CST
Calamos Investments((R))*, a globally diversified investment management firm, released its quarterly Global Economic Review and Outlook. The outlook provides the firm's views on the current economic environment and discusses factors that may affect the global markets and investing opportunities and risks. Calamos invites you to read the entire October 2014 Global Economic Review and Outlook at www.calamos.com/outlook [http://www.calamos.com/Outlook].
CLMS: 12.41 (-0.50)

Calamos Focus Growth Exchange Traded Fund (NASDAQ: CFGE) Announces Annual Distribution for December 2014
PR Newswire - Wed Nov 26, 3:01PM CST
Calamos Investments®* announced today the declaration of an annual distribution on each common share for its actively managed exchange traded fund, Calamos Focus Growth ETF (NASDAQ: CFGE).
CLMS: 12.41 (-0.50), CFGE: 10.27 (-0.02)

Calamos Asset Management, Inc. Announces Share Repurchase Program
PR Newswire - Thu Nov 13, 3:01PM CST
Calamos Asset Management, Inc. (NASDAQ: CLMS), representing the public shares outstanding, owns 22.2% of the operating company, Calamos Investments LLC, with the remaining 77.8% privately owned by Calamos Family Partners, Inc. Calamos Asset Management, Inc. and Calamos Investments LLC together operate a diversified global investment firm offering equity, fixed income, convertible and alternative strategies, and today reported that the Board of Directors of Calamos Asset Management, Inc. approved a share repurchase program to acquire up to 3 million shares of the company's outstanding Class A Common Stock by Calamos Investments LLC.
CLMS: 12.41 (-0.50)

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for November 2014
PR Newswire - Fri Oct 31, 3:01PM CDT
Calamos Investments®* announced today the declaration of monthly distributions on each common share for its five closed-end funds.
CLMS: 12.41 (-0.50)

Stocks Going Ex-Dividend The First Week Of November
Stockerblog - at Seeking Alpha - Tue Oct 28, 9:15PM CDT
Here is our latest update on the stock trading technique called "Buying Dividends," also commonly referred to as "Dividend Capture." This is the process of buying stocks before the ex-dividend date and selling the stock shortly...
CLMS: 12.41 (-0.50), SRCE: 31.20 (+0.07), BTU: 7.37 (-0.04), MWE: 61.80 (+0.07), NFBK: 14.12 (-0.18), MDC: 24.76 (-0.24), XLNX: 45.16 (-0.88), MPB: 15.55 (-0.21), CFNL: 18.81 (unch), DCOM: 15.45 (-0.09), BBDO: 12.60 (-0.60), IDA: 62.45 (-0.97), WSCI: 6.38 (+0.03)

Calamos Asset Management's (CLMS) CEO John Calamos on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 6:54PM CDT

CLMS: 12.41 (-0.50)

Calamos Asset Management posts 3Q profit
Automated Insights - Thu Oct 23, 6:19PM CDT
NAPERVILLE, Ill. (AP) _ Calamos Asset Management Inc. (CLMS) on Thursday reported net income of $3.4 million in its third quarter.
CLMS: 12.41 (-0.50)

Calamos Asset Management declares $0.15 dividend
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:34PM CDT

CLMS: 12.41 (-0.50)

Calamos Asset Management beats by $0.11, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 3:22PM CDT

CLMS: 12.41 (-0.50)

Calamos Asset Management, Inc. Reports Third Quarter 2014 Results and Declares Dividend
PR Newswire - Thu Oct 23, 3:01PM CDT
Calamos Asset Management, Inc. (NASDAQ: CLMS), representing the public shares outstanding, owns 22.2% of the operating company, Calamos Investments LLC, with the remaining 77.8% privately owned by Calamos Family Partners, Inc. Calamos Asset Management, Inc. (CAM) and Calamos Investments LLC together operate a diversified global investment firm offering equity, fixed income, convertible and alternative strategies, and today reported consolidated results for third quarter 2014 and comparative periods.
CLMS: 12.41 (-0.50), CFGE: 10.27 (-0.02)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:35PM CDT

MXIM: 30.63 (-0.16), GHL: 39.78 (-1.48), HBHC: 29.40 (-0.82), HWAY: 18.67 (+0.01), DV: 46.13 (-1.08), FET: 17.82 (-0.81), CLNE: 4.57 (-0.10), ADES: 20.38 (-0.83), FII: 31.70 (-1.35), LOGM: 49.67 (+0.36), MSFT: 46.95 (-0.22), BLDR: 6.11 (-0.15), CLMS: 12.41 (-0.50), PDFS: 12.59 (-0.14), IM: 26.31 (-0.71), NCR: 27.52 (-0.53), EW: 128.87 (-3.20), POL: 35.05 (-0.74), DLB: 43.24 (-0.87), HUBG: 35.82 (-0.27), PFPT: 45.82 (-1.57), PFG: 50.59 (-2.71), NTGR: 34.17 (-0.94), PCCC: 23.62 (+0.17), FSL: 24.77 (+0.21), CTCT: 34.02 (-1.08), BMRN: 91.52 (-1.38), RUBI: 14.81 (-0.12), OLN: 22.18 (-1.27), ALTR: 37.03 (-0.65), CB: 101.84 (-1.46), N: 103.89 (-0.87), MTSN: 3.19 (+0.17), JNPR: 21.10 (-0.27), MXWL: 8.63 (-0.47), GIMO: 16.04 (-0.06), INFA: 37.39 (-0.31), ELY: 7.23 (+0.01), P: 17.35 (-0.12), RMD: 53.46 (-0.13), CNMD: 43.54 (-0.52), BJRI: 48.23 (-0.06), PEB: 43.89 (-0.24), CERN: 61.44 (-1.89), CBI: 39.14 (-1.17), AMZN: 307.32 (-0.04), ECHO: 27.67 (-0.23), ALGN: 55.73 (-0.73), LSCC: 6.28 (-0.20), DECK: 96.98 (+0.75), CYN: 77.75 (-0.63), PACB: 6.81 (+0.04), QLIK: 29.37 (-1.03), CPWR: 10.34 (unch), FLS: 54.87 (-2.45), BAS: 5.22 (+0.05), KLAC: 68.63 (-0.52)

Upgrade Alert for Calamos Asset Management (CLMS)
Comtex SmarTrend(R) - Wed Oct 08, 7:01AM CDT
Calamos Asset Management (NASDAQ:CLMS) was upgraded from Underperform to Market Perform at Keefe Bruyette today. The stock closed yesterday at $11.62 on volume of 144,000 shares, above average daily volume of 94,000. In the past 52 weeks, shares of Calamos Asset Management have traded between a low of $9.46 and a high of $13.90 and closed yesterday at $11.62, which is 23% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.6%.
CLMS: 12.41 (-0.50)

Calamos Asset Management, Inc. Announces Third Quarter 2014 Investor Conference Call
PR Newswire - Tue Oct 07, 3:01PM CDT
Calamos Asset Management, Inc. (NASDAQ: CLMS) will announce earnings for the third quarter of 2014 after the financial markets close on Thursday, October 23, 2014. An investor conference call is scheduled that day at 3:30 p.m. Central Time.
CLMS: 12.41 (-0.50)

FXA, GOODO, CLMS, SLW, LMAT, CYCCP Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 30, 3:32AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of CurrencyShares Australian Dollar Trust (NYSE:FXA), Gladstone Commercial Corp (NASDAQ:GOODO), Calamos Asset Management Inc (NASDAQ:CLMS), Silver Wheaton Corp (NYSE:SLW), LeMaitre Vascular Inc (NASDAQ:LMAT), Cyclacel Pharmaceuticals Inc (NASDAQ:CYCCP) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CLMS: 12.41 (-0.50), CYCC: 2.94 (+0.03), FXA: 82.60 (-0.04), LMAT: 7.40 (+0.20), GOOD: 17.67 (-0.15), SLW: 20.59 (-0.23), CYCCP: 6.60 (-0.40), GOODO: 25.45 (+0.08)

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for October 2014
PR Newswire - Mon Sep 29, 3:01PM CDT
Calamos Investments®* announced today the declaration of monthly distributions on each common share for its five closed-end funds.
CLMS: 12.41 (-0.50)

Calamos Closed-End Funds (NASDAQ: CHI, CHW) Revise Allocation Estimates for September 2014
PR Newswire - Thu Sep 04, 3:01PM CDT
Calamos Investments®* revised its estimates regarding the amounts allocated between ordinary income and return of capital for the September distributions of CHI and CHW. The previously declared September distributions for CHI and CHW remain unchanged.
CLMS: 12.41 (-0.50), CHW: 8.50 (-0.07), CHI: 12.87 (-0.13)

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for September 2014
PR Newswire - Fri Aug 29, 3:01PM CDT
Calamos Investments®* announced today the declaration of monthly distributions on each common share for its five closed-end funds.
CLMS: 12.41 (-0.50)

GBLI, IBIO, HBOS, CASS, CLMS Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Aug 18, 7:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Global Indemnity PLC (NASDAQ:GBLI), Ibio Inc (NYSE:IBIO), Heritage Financial Group Inc (NASDAQ:HBOS), CASS INFORMATION SYSTEMS, INC. (NASDAQ:CASS), Calamos Asset Management Inc (NASDAQ:CLMS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CLMS: 12.41 (-0.50), CASS: 47.58 (-0.14), IBIO: 0.69 (unch), GBLI: 27.31 (+0.09), HBOS: 25.23 (-0.17)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading